HEADER TOXIN 13-APR-10 3AH2 TITLE HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH TITLE 2 N-ACETYLGALACTOSAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAIN HEMAGGLUTININ COMPONENT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN, COMPND 5 HEMAGGLUTININ COMPONENT HA1, HA 33 KDA SUBUNIT, HA1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM; SOURCE 3 ORGANISM_TAXID: 1491; SOURCE 4 STRAIN: TYPE C; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PMAL-2X FLAG-HA1 KEYWDS TOXIN, BETA TREFOIL, HEMAGGLUTININ EXPDTA X-RAY DIFFRACTION AUTHOR T.NAKAMURA,T.TONOZUKA,A.IDE,T.YUZAWA,K.OGUMA,A.NISHIKAWA REVDAT 3 01-NOV-23 3AH2 1 HETSYN REVDAT 2 29-JUL-20 3AH2 1 COMPND REMARK SEQADV HETNAM REVDAT 2 2 1 SITE REVDAT 1 28-APR-10 3AH2 0 SPRSDE 28-APR-10 3AH2 2EHM JRNL AUTH T.NAKAMURA,T.TONOZUKA,A.IDE,T.YUZAWA,K.OGUMA,A.NISHIKAWA JRNL TITL SUGAR-BINDING SITES OF THE HA1 SUBCOMPONENT OF CLOSTRIDIUM JRNL TITL 2 BOTULINUM TYPE C PROGENITOR TOXIN JRNL REF J.MOL.BIOL. V. 376 854 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18178224 JRNL DOI 10.1016/J.JMB.2007.12.031 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.NAKAMURA,N.TAKADA,T.TONOZUKA,Y.SAKANO,K.OGUMA,A.NISHIKAWA REMARK 1 TITL BINDING PROPERTIES OF CLOSTRIDIUM BOTULINUM TYPE C REMARK 1 TITL 2 PROGENITOR TOXIN TO MUCINS REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1770 551 2007 REMARK 1 REFN ISSN 0006-3002 REMARK 1 PMID 17196748 REMARK 1 DOI 10.1016/J.BBAGEN.2006.11.006 REMARK 1 REFERENCE 2 REMARK 1 AUTH N.UOTSU,A.NISHIKAWA,T.WATANABE,T.OHYAMA,T.TONOZUKA,Y.SAKANO, REMARK 1 AUTH 2 K.OGUMA REMARK 1 TITL CELL INTERNALIZATION AND TRAFFIC PATHWAY OF CLOSTRIDIUM REMARK 1 TITL 2 BOTULINUM TYPE C NEUROTOXIN IN HT-29 CELLS REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1763 120 2006 REMARK 1 REFN ISSN 0006-3002 REMARK 1 PMID 16413070 REMARK 1 DOI 10.1016/J.BBAMCR.2005.11.014 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0099 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 66722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 7496 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4782 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.57 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE SET COUNT : 519 REMARK 3 BIN FREE R VALUE : 0.2580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4720 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 788 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.108 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4881 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6665 ; 1.191 ; 1.914 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 582 ; 7.201 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 274 ;39.843 ;25.912 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 846 ;11.836 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;16.280 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 741 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3765 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2855 ; 0.641 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4672 ; 1.219 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2026 ; 1.802 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1984 ; 2.903 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3AH2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000029244. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74218 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.31200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1QXM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% ETHANOL, 1.7M SODIUM CHLORIDE, PH REMARK 280 6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 68.96850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.03050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 68.96850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.03050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TRP A -1 REMARK 465 ILE A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 TRP B -1 REMARK 465 ILE B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLN B 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLU A 203 O4 NGA B 2000 2656 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 66 -16.32 93.90 REMARK 500 ARG A 102 -0.06 73.42 REMARK 500 ASP A 122 -0.47 73.53 REMARK 500 PHE A 179 30.19 -140.34 REMARK 500 ASN B 66 -4.08 86.57 REMARK 500 ASN B 74 47.72 -77.39 REMARK 500 ARG B 102 -0.26 72.68 REMARK 500 THR B 130 -161.57 -118.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QXM RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE UNLIGANDED FORM REMARK 900 RELATED ID: 3AH1 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH SIALIC ACID REMARK 900 RELATED ID: 3AH4 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GALACTOSE DBREF 3AH2 A 1 286 UNP P46084 HA33_CLOBO 1 286 DBREF 3AH2 B 1 286 UNP P46084 HA33_CLOBO 1 286 SEQADV 3AH2 TRP A -1 UNP P46084 EXPRESSION TAG SEQADV 3AH2 ILE A 0 UNP P46084 EXPRESSION TAG SEQADV 3AH2 TRP B -1 UNP P46084 EXPRESSION TAG SEQADV 3AH2 ILE B 0 UNP P46084 EXPRESSION TAG SEQRES 1 A 288 TRP ILE MET SER GLN THR ASN ALA ASN ASP LEU ARG ASN SEQRES 2 A 288 ASN GLU VAL PHE PHE ILE SER PRO SER ASN ASN THR ASN SEQRES 3 A 288 LYS VAL LEU ASP LYS ILE SER GLN SER GLU VAL LYS LEU SEQRES 4 A 288 TRP ASN LYS LEU SER GLY ALA ASN GLN LYS TRP ARG LEU SEQRES 5 A 288 ILE TYR ASP THR ASN LYS GLN ALA TYR LYS ILE LYS VAL SEQRES 6 A 288 MET ASP ASN THR SER LEU ILE LEU THR TRP ASN ALA PRO SEQRES 7 A 288 LEU SER SER VAL SER VAL LYS THR ASP THR ASN GLY ASP SEQRES 8 A 288 ASN GLN TYR TRP TYR LEU LEU GLN ASN TYR ILE SER ARG SEQRES 9 A 288 ASN VAL ILE ILE ARG ASN TYR MET ASN PRO ASN LEU VAL SEQRES 10 A 288 LEU GLN TYR ASN ILE ASP ASP THR LEU MET VAL SER THR SEQRES 11 A 288 GLN THR SER SER SER ASN GLN PHE PHE LYS PHE SER ASN SEQRES 12 A 288 CYS ILE TYR GLU ALA LEU ASN ASN ARG ASN CYS LYS LEU SEQRES 13 A 288 GLN THR GLN LEU ASN SER ASP ARG PHE LEU SER LYS ASN SEQRES 14 A 288 LEU ASN SER GLN ILE ILE VAL LEU TRP GLN TRP PHE ASP SEQRES 15 A 288 SER SER ARG GLN LYS TRP ILE ILE GLU TYR ASN GLU THR SEQRES 16 A 288 LYS SER ALA TYR THR LEU LYS CYS GLN GLU ASN ASN ARG SEQRES 17 A 288 TYR LEU THR TRP ILE GLN ASN SER ASN ASN TYR VAL GLU SEQRES 18 A 288 THR TYR GLN SER THR ASP SER LEU ILE GLN TYR TRP ASN SEQRES 19 A 288 ILE ASN TYR LEU ASP ASN ASP ALA SER LYS TYR ILE LEU SEQRES 20 A 288 TYR ASN LEU GLN ASP THR ASN ARG VAL LEU ASP VAL TYR SEQRES 21 A 288 ASN SER GLN ILE ALA ASN GLY THR HIS VAL ILE VAL ASP SEQRES 22 A 288 SER TYR HIS GLY ASN THR ASN GLN GLN TRP ILE ILE ASN SEQRES 23 A 288 LEU ILE SEQRES 1 B 288 TRP ILE MET SER GLN THR ASN ALA ASN ASP LEU ARG ASN SEQRES 2 B 288 ASN GLU VAL PHE PHE ILE SER PRO SER ASN ASN THR ASN SEQRES 3 B 288 LYS VAL LEU ASP LYS ILE SER GLN SER GLU VAL LYS LEU SEQRES 4 B 288 TRP ASN LYS LEU SER GLY ALA ASN GLN LYS TRP ARG LEU SEQRES 5 B 288 ILE TYR ASP THR ASN LYS GLN ALA TYR LYS ILE LYS VAL SEQRES 6 B 288 MET ASP ASN THR SER LEU ILE LEU THR TRP ASN ALA PRO SEQRES 7 B 288 LEU SER SER VAL SER VAL LYS THR ASP THR ASN GLY ASP SEQRES 8 B 288 ASN GLN TYR TRP TYR LEU LEU GLN ASN TYR ILE SER ARG SEQRES 9 B 288 ASN VAL ILE ILE ARG ASN TYR MET ASN PRO ASN LEU VAL SEQRES 10 B 288 LEU GLN TYR ASN ILE ASP ASP THR LEU MET VAL SER THR SEQRES 11 B 288 GLN THR SER SER SER ASN GLN PHE PHE LYS PHE SER ASN SEQRES 12 B 288 CYS ILE TYR GLU ALA LEU ASN ASN ARG ASN CYS LYS LEU SEQRES 13 B 288 GLN THR GLN LEU ASN SER ASP ARG PHE LEU SER LYS ASN SEQRES 14 B 288 LEU ASN SER GLN ILE ILE VAL LEU TRP GLN TRP PHE ASP SEQRES 15 B 288 SER SER ARG GLN LYS TRP ILE ILE GLU TYR ASN GLU THR SEQRES 16 B 288 LYS SER ALA TYR THR LEU LYS CYS GLN GLU ASN ASN ARG SEQRES 17 B 288 TYR LEU THR TRP ILE GLN ASN SER ASN ASN TYR VAL GLU SEQRES 18 B 288 THR TYR GLN SER THR ASP SER LEU ILE GLN TYR TRP ASN SEQRES 19 B 288 ILE ASN TYR LEU ASP ASN ASP ALA SER LYS TYR ILE LEU SEQRES 20 B 288 TYR ASN LEU GLN ASP THR ASN ARG VAL LEU ASP VAL TYR SEQRES 21 B 288 ASN SER GLN ILE ALA ASN GLY THR HIS VAL ILE VAL ASP SEQRES 22 B 288 SER TYR HIS GLY ASN THR ASN GLN GLN TRP ILE ILE ASN SEQRES 23 B 288 LEU ILE HET NGA B2000 15 HETNAM NGA 2-ACETAMIDO-2-DEOXY-BETA-D-GALACTOPYRANOSE HETSYN NGA N-ACETYL-BETA-D-GALACTOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NGA BETA-D-GALACTOSE; 2-ACETAMIDO-2-DEOXY-D-GALACTOSE; 2- HETSYN 3 NGA ACETAMIDO-2-DEOXY-GALACTOSE; N-ACETYL-D-GALACTOSAMINE FORMUL 3 NGA C8 H15 N O6 FORMUL 4 HOH *788(H2 O) HELIX 1 1 GLY A 43 GLN A 46 5 4 HELIX 2 2 GLY A 88 GLN A 91 5 4 HELIX 3 3 SER A 132 GLN A 135 5 4 HELIX 4 4 CYS A 142 ASN A 148 1 7 HELIX 5 5 SER A 181 GLN A 184 5 4 HELIX 6 6 SER A 226 GLN A 229 5 4 HELIX 7 7 ASN A 259 GLN A 261 5 3 HELIX 8 8 ASN A 276 GLN A 279 5 4 HELIX 9 9 GLY B 43 GLN B 46 5 4 HELIX 10 10 GLY B 88 GLN B 91 5 4 HELIX 11 11 SER B 132 GLN B 135 5 4 HELIX 12 12 CYS B 142 ASN B 148 1 7 HELIX 13 13 SER B 181 GLN B 184 5 4 HELIX 14 14 SER B 226 GLN B 229 5 4 HELIX 15 15 ASN B 259 GLN B 261 5 3 HELIX 16 16 ASN B 276 GLN B 279 5 4 SHEET 1 A 4 ALA A 58 VAL A 63 0 SHEET 2 A 4 TRP A 48 ASP A 53 -1 N ASP A 53 O ALA A 58 SHEET 3 A 4 VAL A 14 PRO A 19 -1 N PHE A 15 O TRP A 48 SHEET 4 A 4 PHE A 137 ASN A 141 -1 O LYS A 138 N SER A 18 SHEET 1 B 2 LYS A 25 LYS A 29 0 SHEET 2 B 2 VAL A 35 ASN A 39 -1 O TRP A 38 N VAL A 26 SHEET 1 C 2 ILE A 70 TRP A 73 0 SHEET 2 C 2 VAL A 80 LYS A 83 -1 O SER A 81 N THR A 72 SHEET 1 D 2 TRP A 93 GLN A 97 0 SHEET 2 D 2 VAL A 104 ASN A 108 -1 O ARG A 107 N TYR A 94 SHEET 1 E 2 LEU A 114 TYR A 118 0 SHEET 2 E 2 LEU A 124 THR A 128 -1 O MET A 125 N GLN A 117 SHEET 1 F 6 VAL A 218 TYR A 221 0 SHEET 2 F 6 ARG A 206 TRP A 210 -1 N TYR A 207 O TYR A 221 SHEET 3 F 6 ALA A 196 CYS A 201 -1 N LEU A 199 O LEU A 208 SHEET 4 F 6 TRP A 186 ASN A 191 -1 N ASN A 191 O ALA A 196 SHEET 5 F 6 ARG A 150 THR A 156 -1 N CYS A 152 O TRP A 186 SHEET 6 F 6 TRP A 281 LEU A 285 -1 O ILE A 282 N GLN A 155 SHEET 1 G 2 PHE A 163 LYS A 166 0 SHEET 2 G 2 ILE A 173 TRP A 176 -1 O VAL A 174 N SER A 165 SHEET 1 H 2 TRP A 231 LEU A 236 0 SHEET 2 H 2 ASP A 239 ASN A 247 -1 O TYR A 246 N ASN A 232 SHEET 1 I 2 ARG A 253 VAL A 257 0 SHEET 2 I 2 VAL A 268 SER A 272 -1 O ILE A 269 N ASP A 256 SHEET 1 J 4 ALA B 58 VAL B 63 0 SHEET 2 J 4 TRP B 48 ASP B 53 -1 N ARG B 49 O LYS B 62 SHEET 3 J 4 VAL B 14 PRO B 19 -1 N PHE B 15 O TRP B 48 SHEET 4 J 4 PHE B 137 ASN B 141 -1 O LYS B 138 N SER B 18 SHEET 1 K 2 LYS B 25 LYS B 29 0 SHEET 2 K 2 VAL B 35 ASN B 39 -1 O TRP B 38 N VAL B 26 SHEET 1 L 2 ILE B 70 TRP B 73 0 SHEET 2 L 2 VAL B 80 LYS B 83 -1 O SER B 81 N THR B 72 SHEET 1 M 2 TRP B 93 GLN B 97 0 SHEET 2 M 2 VAL B 104 ASN B 108 -1 O ARG B 107 N TYR B 94 SHEET 1 N 2 LEU B 114 TYR B 118 0 SHEET 2 N 2 LEU B 124 THR B 128 -1 O SER B 127 N VAL B 115 SHEET 1 O 4 ALA B 196 CYS B 201 0 SHEET 2 O 4 TRP B 186 ASN B 191 -1 N ASN B 191 O ALA B 196 SHEET 3 O 4 ARG B 150 THR B 156 -1 N CYS B 152 O TRP B 186 SHEET 4 O 4 TRP B 281 LEU B 285 -1 O ILE B 282 N GLN B 155 SHEET 1 P 2 PHE B 163 LYS B 166 0 SHEET 2 P 2 ILE B 173 TRP B 176 -1 O VAL B 174 N SER B 165 SHEET 1 Q 2 TYR B 207 TRP B 210 0 SHEET 2 Q 2 VAL B 218 TYR B 221 -1 O TYR B 221 N TYR B 207 SHEET 1 R 2 TRP B 231 LEU B 236 0 SHEET 2 R 2 ASP B 239 ASN B 247 -1 O TYR B 246 N ASN B 232 SHEET 1 S 2 ARG B 253 VAL B 257 0 SHEET 2 S 2 VAL B 268 SER B 272 -1 O ILE B 269 N ASP B 256 CISPEP 1 ALA A 75 PRO A 76 0 2.23 CISPEP 2 ALA B 75 PRO B 76 0 6.20 CRYST1 137.937 62.061 82.426 90.00 104.22 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007250 0.000000 0.001838 0.00000 SCALE2 0.000000 0.016113 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012516 0.00000